midostaurin

Italy

Drugs containing this active substance

  • RYDAPT

    Rydapt is used to treat acute myeloid leukemia (AML) in adults with a FLT3 gene mutation. It is also indicated for the treatment of aggressive systemic mastocytosis (ASM), systemic mastocytosis associated with hematologic neoplasia (SM-AHN), or mast cell leukemia (MCL).

    Form: capsules, soft gelatin

    Active substance Dosage
    midostaurin -

    ATC: L01EX10

    Manufacturer: NOVARTIS EUROPHARM LIMITED